F11R expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 5.04719999128156E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.24470000551736E-08 |
Normal-vs-Stage2 |
1.320350E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.658100E-02 |
Stage1-vs-Stage2 |
1.097600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.521800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
8.033000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.60510000530346E-08 |
Normal-vs-AfricanAmerican |
1.632010E-01 |
Normal-vs-Asian |
1.005800E-04 |
Caucasian-vs-AfricanAmerican |
6.903200E-01 |
Caucasian-vs-Asian |
5.082100E-03 |
AfricanAmerican-vs-Asian |
6.549800E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.372800E-04 |
Normal-vs-Female |
3.18929999998385E-06 |
Male-vs-Female |
5.900800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.815700E-03 |
Normal-vs-Extreme_Weight |
1.954730E-04 |
Normal-vs-Obese |
4.678500E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
2.779200E-01 |
Normal_Weight-vs-Obese |
3.427800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
8.699400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.620400E-01 |
Normal-vs-Age(41-60Yrs) |
5.88280000000108E-05 |
Normal-vs-Age(61-80Yrs) |
7.78090000000953E-05 |
Normal-vs-Age(81-100Yrs) |
2.22350000000926E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.192400E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.563800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.962600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.570830E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.560100E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.649800E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
6.474800E-01 |
Normal-vs-Grade 3 |
7.678800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.022800E-01 |
Grade 2-vs-Grade 4 |
6.474800E-01 |
Grade 3-vs-Grade 4 |
7.678800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.87770000051424E-08 |
Normal-vs-N1 |
3.833900E-02 |
N0-vs-N1 |
2.289400E-01 |
|
|